A Study of PCSK9 Inhibitor AK102 in Healthy Subjects

Condition:   Hypercholesterolaemia Interventions:   Drug: AK102;   Drug: Placebo Sponsors:   Akeso;   AD Pharmaceuticals Co., Ltd. (Guangzhou) Completed

Source: ClinicalTrials.gov - November 19, 2019 Category: Research Source Type: clinical trials